TNF and Cowden syndrome 1: Five weeks of post-treatment with Bresol® (250 and 500 mg/kg, p.o.)showed significant and dose-dependent anti-inflammatory effects against CS-induced lung abnormalities by maintaining the TNF-α and total protein levels within the normal range.